Jin Seok Ahn
Chungnam National University(KR)Samsung Medical Center(KR)Sungkyunkwan University(KR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer(2017)2,414 cited
- → Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma(2020)1,279 cited
- → Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study(2020)662 cited
- → Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study(2015)581 cited
- → DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load(2019)549 cited
- → Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)(2019)